
Adolf D. Berhane
Examiner (ID: 2145, Phone: (571)272-2077 , Office: P/2838 )
| Most Active Art Unit | 2838 |
| Art Unit(s) | 2102, 2111, 2722, 2838, 2899 |
| Total Applications | 4100 |
| Issued Applications | 3647 |
| Pending Applications | 180 |
| Abandoned Applications | 306 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6031080
[patent_doc_number] => 20110081365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-07
[patent_title] => 'COMPOUNDS AND COMPOSITIONS AS TLR ACTIVITY MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 12/921129
[patent_app_country] => US
[patent_app_date] => 2009-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 122852
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20110081365.pdf
[firstpage_image] =>[orig_patent_app_number] => 12921129
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/921129 | Compounds and compositions as TLR activity modulators | Feb 26, 2009 | Issued |
Array
(
[id] => 102873
[patent_doc_number] => 07723385
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-25
[patent_title] => 'Aniline derivatives as selective androgen receptor modulators'
[patent_app_type] => utility
[patent_app_number] => 12/392687
[patent_app_country] => US
[patent_app_date] => 2009-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28914
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/723/07723385.pdf
[firstpage_image] =>[orig_patent_app_number] => 12392687
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/392687 | Aniline derivatives as selective androgen receptor modulators | Feb 24, 2009 | Issued |
Array
(
[id] => 5380359
[patent_doc_number] => 20090192198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-30
[patent_title] => 'INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME'
[patent_app_type] => utility
[patent_app_number] => 12/390318
[patent_app_country] => US
[patent_app_date] => 2009-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 45135
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20090192198.pdf
[firstpage_image] =>[orig_patent_app_number] => 12390318
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/390318 | INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME | Feb 19, 2009 | Abandoned |
Array
(
[id] => 6097674
[patent_doc_number] => 20110003797
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-06
[patent_title] => 'HEXAHYDROCYCLOPENTYL[f]INDAZOLE CARBOXAMIDES AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 12/919049
[patent_app_country] => US
[patent_app_date] => 2009-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14731
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20110003797.pdf
[firstpage_image] =>[orig_patent_app_number] => 12919049
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/919049 | Hexahydrocyclopentyl[F]indazole carboxamides and derivatives thereof as selective glucocorticoid receptor modulators | Feb 15, 2009 | Issued |
Array
(
[id] => 6343787
[patent_doc_number] => 20100330136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-30
[patent_title] => 'USE OF CATIONIC SURFACTANTS FOR THE PROTECTION AGANST TOOTH EROSION'
[patent_app_type] => utility
[patent_app_number] => 12/812813
[patent_app_country] => US
[patent_app_date] => 2009-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3918
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0330/20100330136.pdf
[firstpage_image] =>[orig_patent_app_number] => 12812813
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/812813 | USE OF CATIONIC SURFACTANTS FOR THE PROTECTION AGANST TOOTH EROSION | Feb 10, 2009 | Abandoned |
Array
(
[id] => 5534137
[patent_doc_number] => 20090233925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-17
[patent_title] => 'Hepatitis C Virus Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/368465
[patent_app_country] => US
[patent_app_date] => 2009-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41402
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20090233925.pdf
[firstpage_image] =>[orig_patent_app_number] => 12368465
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/368465 | Hepatitis C virus inhibitors | Feb 9, 2009 | Issued |
Array
(
[id] => 8201234
[patent_doc_number] => 08188131
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-29
[patent_title] => 'Compounds that enhance Atoh1 expression'
[patent_app_type] => utility
[patent_app_number] => 12/368173
[patent_app_country] => US
[patent_app_date] => 2009-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 87
[patent_figures_cnt] => 212
[patent_no_of_words] => 34015
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/188/08188131.pdf
[firstpage_image] =>[orig_patent_app_number] => 12368173
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/368173 | Compounds that enhance Atoh1 expression | Feb 8, 2009 | Issued |
Array
(
[id] => 5480732
[patent_doc_number] => 20090203689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'ABCA-1 ELEVATING COMPOUNDS AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 12/367062
[patent_app_country] => US
[patent_app_date] => 2009-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 22464
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20090203689.pdf
[firstpage_image] =>[orig_patent_app_number] => 12367062
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/367062 | ABCA-1 ELEVATING COMPOUNDS AND METHODS | Feb 5, 2009 | Abandoned |
Array
(
[id] => 6097937
[patent_doc_number] => 20110003842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-06
[patent_title] => 'MARKER FOR DETERMINATION OF SENSITIVITY TO ANTI-CANCER AGENT'
[patent_app_type] => utility
[patent_app_number] => 12/865725
[patent_app_country] => US
[patent_app_date] => 2009-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6167
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20110003842.pdf
[firstpage_image] =>[orig_patent_app_number] => 12865725
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/865725 | Marker for determination of sensitivity to anti-cancer agent | Jan 29, 2009 | Issued |
Array
(
[id] => 9983698
[patent_doc_number] => 09029411
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-12
[patent_title] => 'Thiophenes and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/321871
[patent_app_country] => US
[patent_app_date] => 2009-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21285
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12321871
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/321871 | Thiophenes and uses thereof | Jan 25, 2009 | Issued |
Array
(
[id] => 9227583
[patent_doc_number] => 08633251
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-01-21
[patent_title] => 'Derivatives of aminoalkanols, method of obtaining of aminoalkanols and their use'
[patent_app_type] => utility
[patent_app_number] => 12/863881
[patent_app_country] => US
[patent_app_date] => 2009-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 22287
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12863881
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/863881 | Derivatives of aminoalkanols, method of obtaining of aminoalkanols and their use | Jan 18, 2009 | Issued |
Array
(
[id] => 6495113
[patent_doc_number] => 20100009986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-14
[patent_title] => 'SUBSTITUTED HETEROARYL DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 12/373947
[patent_app_country] => US
[patent_app_date] => 2007-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 134523
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20100009986.pdf
[firstpage_image] =>[orig_patent_app_number] => 12373947
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/373947 | Substituted heteroaryl derivatives | Jan 14, 2009 | Issued |
Array
(
[id] => 9239271
[patent_doc_number] => 08604063
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-10
[patent_title] => 'Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies'
[patent_app_type] => utility
[patent_app_number] => 12/811931
[patent_app_country] => US
[patent_app_date] => 2009-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13442
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12811931
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/811931 | Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies | Jan 11, 2009 | Issued |
Array
(
[id] => 6449185
[patent_doc_number] => 20100280127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-04
[patent_title] => 'INHIBITING NEUROTRANSMITTER REUPTAKE'
[patent_app_type] => utility
[patent_app_number] => 12/812337
[patent_app_country] => US
[patent_app_date] => 2009-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 27876
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20100280127.pdf
[firstpage_image] =>[orig_patent_app_number] => 12812337
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/812337 | Inhibiting neurotransmitter reuptake | Jan 8, 2009 | Issued |
Array
(
[id] => 5343282
[patent_doc_number] => 20090181932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-16
[patent_title] => 'COMPOSITIONS CONTAINING O-SULFATE AND O-PHOSPHATE CONTAINING ARYL SULFONAMIDE DERIVATIVES USEFUL AS beta-AMYLOID INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/349850
[patent_app_country] => US
[patent_app_date] => 2009-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8868
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20090181932.pdf
[firstpage_image] =>[orig_patent_app_number] => 12349850
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/349850 | COMPOSITIONS CONTAINING O-SULFATE AND O-PHOSPHATE CONTAINING ARYL SULFONAMIDE DERIVATIVES USEFUL AS beta-AMYLOID INHIBITORS | Jan 6, 2009 | Abandoned |
Array
(
[id] => 6433867
[patent_doc_number] => 20100278828
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-04
[patent_title] => 'COMBINATION OF ANTI-CTLA4 ANTIBODY WITH TUBULIN MODULATING AGENTS FOR THE TREATMENT OF PROLIFERATIVE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/811867
[patent_app_country] => US
[patent_app_date] => 2009-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 18314
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0278/20100278828.pdf
[firstpage_image] =>[orig_patent_app_number] => 12811867
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/811867 | Combination of anti-CTLA4 antibody with tubulin modulating agents for the treatment of proliferative diseases | Jan 6, 2009 | Issued |
Array
(
[id] => 9850342
[patent_doc_number] => 08952071
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-02-10
[patent_title] => '(Het)aryl-p-quinone derivatives for treatment of mitochondrial diseases'
[patent_app_type] => utility
[patent_app_number] => 12/811694
[patent_app_country] => US
[patent_app_date] => 2009-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28078
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12811694
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/811694 | (Het)aryl-p-quinone derivatives for treatment of mitochondrial diseases | Jan 5, 2009 | Issued |
Array
(
[id] => 5316558
[patent_doc_number] => 20090281156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-12
[patent_title] => 'ENHANCING PHOTOSTABILIZATION OF OXYMETAZOLINE'
[patent_app_type] => utility
[patent_app_number] => 12/339394
[patent_app_country] => US
[patent_app_date] => 2008-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5162
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20090281156.pdf
[firstpage_image] =>[orig_patent_app_number] => 12339394
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/339394 | ENHANCING PHOTOSTABILIZATION OF OXYMETAZOLINE | Dec 18, 2008 | Abandoned |
Array
(
[id] => 6544937
[patent_doc_number] => 20100016279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-21
[patent_title] => 'BICYCLIC DERIVATIVES FOR USE IN THE TREATMENT OF ANDROGEN RECEPTOR ASSOCIATED CONDITIONS-155'
[patent_app_type] => utility
[patent_app_number] => 12/338405
[patent_app_country] => US
[patent_app_date] => 2008-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 156761
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20100016279.pdf
[firstpage_image] =>[orig_patent_app_number] => 12338405
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/338405 | Bicyclic derivatives for use in the treatment of androgen receptor associated conditions-155 | Dec 17, 2008 | Issued |
Array
(
[id] => 5502814
[patent_doc_number] => 20090163502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-25
[patent_title] => 'Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists'
[patent_app_type] => utility
[patent_app_number] => 12/317026
[patent_app_country] => US
[patent_app_date] => 2008-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38805
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0163/20090163502.pdf
[firstpage_image] =>[orig_patent_app_number] => 12317026
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/317026 | Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists | Dec 16, 2008 | Issued |